We recently published a list of 15 Best Large-Cap Value Stocks to Buy as the Recession Hits. In this article, we are going to ...

In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.

In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best dividend monarchs. Dividend-focused investors are generally well-acquainted with terms like ...

Shares of AbbVie Inc. ABBV shed 2.90% to $171.68 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 2.24% to 5,275.70 and Dow ...

In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other high growth forever dividend stocks. Dividend stocks have trailed the broader market over the ...

In a report released today, Vamil Divan from Guggenheim maintained a Buy rating on AbbVie (ABBV – Research Report), with a price target of ...

Pharmaceutical giant AbbVie issued a new slate of challenges this week against states with laws requiring drugmakers to offer ...

NEW YORK, NY / ACCESS Newswire / April 15, 2025 / If you suffered a loss on your Cerevel Therapeutics Holdings, Inc. (NYSE:ABBV) investment and ...

A significant trading signal occurred for AbbVie stock at $164.86, ahead of tariff reversal news. ABBV climbed up to 9.2% ...

Shares of AbbVie Inc. (NYSE:ABBV – Get Free Report) dropped 0.2% during trading on Thursday after an insider sold shares in the company. The stock traded as low as $204.55 and last traded at $204.69.

Shares of AbbVie Inc. ABBV slid 3.14% to $174.20 Thursday, on what proved to be an all-around dismal trading session for the ...